Advanced Search

The American Journal of Psychiatry, VOL. 127, No. 1

Articles | July 01, 1970

An Evaluation of Niacinamide in the Treatment of Childhood Schizophrenia

GERALD H. C. GREENBAUM

Am J Psychiatry 1970;127:89-92.

Clinical teacher, department of psychiatry, faculty of medicine, University of Toronto, and staff psychiatrist, department of psychiatry, the Hospital for Sick Children, 555 University Ave., Toronto 2, Canada

1971, American Psychiatric Association

Article

text A A A

PDF of the full text article.

Abstract

The author evaluated 57 schizophrenic children clinically and psychologically before and after a six-month administration of niacinamide. They were separated into three groups: those given niacinamide, those given niacinamide plus a tranquilizer, and those given a placebo. There was no significant difference attributable to niacinamide; also, tests for the "mauve factor" in the urine of 28 of the children were negative.

Figures in this Article

Your Session has timed out. Please sign back in to continue.

Username

Password

Sign in via Athens (What is this?)

Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.

Forgot Password?

Not a subscriber?

Subscribe Now/Learn More

Purchase Online access to this article for 24 hours

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.

Submit a Comments

Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field

Comment Author(s)*(if multiple authors, separate names by comma)

Example: John Doe

Affiliation & Institution*

Comment Title*

Comment*

Cancel

Topics

Product Recommendation

CME Activity